Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial

被引：0
|
作者：
Chen, Yunfei [1 ,2 ]
Xu, Yanmei [1 ,2 ]
Huang, Yueting [3 ]
Sun, Ting [1 ,2 ]
Hu, Yuefen [4 ]
Xue, Feng [1 ,2 ]
Peng, Xuanwei [5 ]
Lai, Yinghui [5 ]
Zhou, Zeping [6 ]
Zhou, Hu [7 ]
Zhou, Rongfu [8 ]
Liu, Wei [1 ,2 ]
Liu, Xiaofan [1 ,2 ]
Dong, Huan [1 ,2 ]
Fu, Rongfeng [1 ,2 ]
Ju, Mankai [1 ,2 ]
Dai, Xinyue [1 ,2 ]
Li, Huiyuan [1 ,2 ]
Liu, Xiaonan [1 ,2 ]
Ma, Yueshen [1 ,2 ]
Song, Zhen [1 ,2 ]
Peng, Jun [4 ,10 ]
Yang, Renchi [1 ,2 ,9 ]
Zhang, Lei [1 ,2 ,9 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Tianjin Key Lab Gene Therapy Blood Dis, CAMS Key Lab Gene Therapy Blood Dis, State Key Lab Expt Hematol,Natl Clin Res Ctr Blood, Tianjin, Peoples R China
[2] Tianjin Inst Hlth Sci, Tianjin, Peoples R China
[3] Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen, Fujian, Peoples R China
[4] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Peoples R China
[5] Guangxi Med Univ, Affiliated Hosp 2, Nanning, Peoples R China
[6] Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China
[7] Henan Canc Hosp, Zhengzhou, Peoples R China
[8] Nanjing Univ, Affiliated Nanjing Drum Tower Hosp, Med Sch, Nanjing, Peoples R China
[9] Chinese Acad Med Sci & Peking Union Med Coll, Tianjin Key Lab Gene Therapy Blood Dis, CAMS Key Lab Gene Therapy Blood Dis, State Key Lab Expt Hematol,Natl Clin Res Ctr Blood, Tianjin 30020, Peoples R China
[10] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Peoples R China
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 01期
基金：
中国国家自然科学基金;
关键词：
LONG-TERM;
D O I：
10.1002/ajh.27141
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E22 / E25
页数：4
相关论文
共 50 条
  • [21] Disorders of Platelet Number or Function: Clinical and Epidemiological Efficacy and Safety of Human Umbilical Cord- Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial
    Chen, Yunfei
    Xu Yanmei
    Gao, Yuchen
    Chi, Ying
    Sun, Ting
    Dou, Xueqing
    Han, Zhibo
    Xue, Feng
    Li, Huiyuan
    Liu, Wei
    Liu, Xiaofan
    Dong, Huan
    Fu, Rongfeng
    Ju, Mankai
    Dai, Xinyue
    Wang, Wentian
    Ma, Yueshen
    Song, Zhen
    Gu, Jundong
    Gong, Wei
    Yang, Renchi
    Zhang, Lei
    BLOOD, 2023, 142
  • [22] Evaluating the Efficacy and Safety of Silodosin on Nocturia in Patients With Benign Prostatic Hyperplasia: A Multicenter, Prospective, Open-label, Single-arm, Phase IV Trial
    Cho, Kang Jun
    Lee, Jeong Zoo
    Song, Yun Seob
    Choi, Jong Bo
    Kim, Dae Kyung
    Kim, Yong Tae
    Kim, Joon Chul
    UROLOGY, 2018, 121 : 153 - 157
  • [23] Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Results on Efficacy, Safety and Quality of Life of an International, Multicenter Prospective, Randomized, Trial
    Oliva, Esther Natalie
    Santini, Valeria
    Alati, Caterina
    Poloni, Antonella
    Molteni, Alfredo
    Niscola, Pasquale
    Sanpaolo, Grazia
    Salvi, Flavia
    Palumbo, Giuseppe A.
    Balleari, Enrico
    Impera, Stefana
    Cortelezzi, Agostino
    Liberati, Anna Marina
    Avanzini, Paolo
    Di Bartolomeo, Paolo
    Rose, Christian
    Beyne-Rauzy, Odile
    Buccisano, Francesco
    Bocchia, Monica
    Morabito, Fortunato
    Stamatoullas, Aspasia
    Ronco, Francesca
    Zini, Gina
    D'Errigo, Maria Grazia
    Ranieri, Natale
    Cufari, Patrizia
    Santacaterina, Irene
    Fenaux, Pierre
    Latagliata, Roberto
    BLOOD, 2015, 126 (23)
  • [24] A prospective, single-arm, phase II trial evaluating the efficacy and safety of niraparib monotherapy maintenance treatment in patients with recurrent and metastatic (R/M) endometrial cancer (EC)
    Zhu, Jianqing
    Wang, Junjian
    Shao, Feng
    Cheng, Feng
    Chen, Zhongbo
    Sun, Lu
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A173 - A174
  • [25] Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial
    Mei, Heng
    Liu, Xiaofan
    Li, Yan
    Zhou, Hu
    Feng, Ying
    Gao, Guangxun
    Cheng, Peng
    Huang, Ruibin
    Yang, Linhua
    Hu, Jianda
    Hou, Ming
    Yao, Yazhou
    Liu, Li
    Wang, Yi
    Wu, Depei
    Shen, Xuliang
    Jin, Jie
    Luo, Jianmin
    Zeng, Yun
    Zhou, Xin
    Xia, Ruixiang
    Jiang, Zhongxing
    Bai, Yuansong
    Niu, Ting
    Yang, Renchi
    Hu, Yu
    ANNALS OF HEMATOLOGY, 2024, 103 (07) : 2273 - 2281
  • [26] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase Ⅱ trial
    Shuzhen Lai
    Peijing Li
    Xiaohui Liu
    Guihong Liu
    Tieming Xie
    Xing Zhang
    Xiaoxuan Wang
    Jing Huang
    Yiqiang Tang
    Zhigang Liu
    Guoping Shen
    Chaoming Li
    Fangxiao Lu
    Lei Wang
    Fagui Jiang
    Caixing Sun
    Yuanyuan Chen
    Ming Chen
    Cancer Biology & Medicine, 2024, 21 (05) : 433 - 444
  • [27] Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial
    Zhengbo Song
    Yuping Li
    Shiqing Chen
    Shenpeng Ying
    Shuguang Xu
    Jianjin Huang
    Dan Wu
    Dongqing Lv
    Ting Bei
    Shuxun Liu
    Xiaoping Huang
    Congying Xie
    Xiaoyu Wu
    Jianfei Fu
    Feng Hua
    Wenxian Wang
    Chunwei Xu
    Chan Gao
    Shangli Cai
    Shun Lu
    Yiping Zhang
    BMC Medicine, 20
  • [28] Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial
    Song, Zhengbo
    Li, Yuping
    Chen, Shiqing
    Ying, Shenpeng
    Xu, Shuguang
    Huang, Jianjin
    Wu, Dan
    Lv, Dongqing
    Bei, Ting
    Liu, Shuxun
    Huang, Xiaoping
    Xie, Congying
    Wu, Xiaoyu
    Fu, Jianfei
    Hua, Feng
    Wang, Wenxian
    Xu, Chunwei
    Gao, Chan
    Cai, Shangli
    Lu, Shun
    Zhang, Yiping
    BMC MEDICINE, 2022, 20 (01)
  • [29] Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial
    Kateera, Fredrick
    Shumbusho, Fabienne
    Manirambona, Linda
    Kabihizi, Jules
    Murangwa, Anthere
    Serumondo, Janvier
    Makuza, Jean Damascene
    Nsanzimana, Sabin
    Muvunyi, Claude Mambo
    Kabakambira, Jean Damascene
    Sylvain, Habarurema
    Camus, Gregory
    Grant, Philip M.
    Gupta, Neil
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (06): : 533 - 541
  • [30] Efficacy and safety of lamivudine in the treatment of chronic hepatitis B virus infection of pregnant women
    Zhao, NF
    Su, GG
    Fang, SH
    Yang, DH
    HEPATOLOGY, 2002, 36 (04) : 631A - 631A
12345